Journal of Pain and Symptom Management
Volume 27, Issue 2 , Pages 99-101 , February 2004

Paracetamol (acetaminophen) allergy

References 

  1. Hermens JM, Ebertz JM, Hanifin JM, et al.  Comparison of histamine release in human skin mast cells induced by morphine, fentanyl and oxymorphone. Anesthesiology. 1985;62(2):124–129
  2. Baumann TJ. Analgesic selection when the patient is allergic to codeine. Clin Pharm. 1991;10(9):658
  3. How many people use retail analgesics? 2002; [6 screens]. Available at: http://www.jr2.ox.ac.uk/bandolier/band106/b106-6.html. Accessed September 24, 2003.
  4. Andrade SE, Martinez C, Walker AM. Comparative safety evaluation of non-narcotic analgesics. J Clin Epidemiol. 1998;51(12):1357–1365
  5. Cole FOA. Urticaria from paracetamol. Clin Exp Dermatol. 1985;10(4):404
  6. Kalyoncu AF, Karakaya G, Sahin AA, et al.  Occurrence of allergic conditions in asthmatics with analgesic intolerance. Allergy. 1999;54(5):428–435
  7. Galindo PA, Borja J, Mur P, et al.  Anaphylaxis to paracetamol. Allergol Immunopathol (Madr). 1998;26(4):199–200 Erratum in: Allergol Immunopathol (Madr) 1998;26(5):2832
  8. Stricker BHC, Meyboom RHB, Lindquist M. Acute hypersensitivity reactions to paracetamol. Br Med J (Clin Res Ed). 1985;291(6500):938–939
  9. van Diem L, Grilliat JP. Anaphylactic shock induced by paracetamol. Eur J Clin Pharmacol. 1990;38(4):389–390
  10. Settipane RA, Schrank PJ, Simon RA, et al.  Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995;96(4):480–485
  11. de Paramo BJ, Gancedo SQ, Cuevas M, et al.  Paracetamol (acetaminophen) hypersensitivity. Ann Allergy Asthma Immunol. 2000;85(6 Pt 1):508–511
  12. Kvedariene V, Bencherioua AM, Messaad D, et al.  The accuracy of the diagnosis of suspected paracetamol (acetaminophen) hypersensitivity: results of a single-blinded trial. Clin Exp Allergy. 2002;32(9):1366–1369
  13. Carvajal A, Prieto JR, Requejo AA, et al.  Aspirin or acetaminophen? A comparison from data collected by the Spanish Drug Monitoring System. J Clin Epidemiol. 1996;49(2):255–261
  14. The Yellow Card Scheme: Who can report. [3 screens]. Available at: http://www.mca.gov.uk/aboutagency/regframework/csm/csmhome.htm. Accessed September 24, 2003.
  15. Monitoring the safety and quality of medicines: Pharmacovigilance. [3 screens]. Available at http://www.mca.gov.uk/ourwork/monitorsafequalmed/pharmacovigilance/pharmacovigilance.htm. Accessed September 23, 2003.
  16. Rawlins MD. Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994. JR Coll Physicians Lond. 1995;29(1):41–49 Erratum in: JR Coll Physicians Lond 1995;29(2):118

PII: S0885-3924(03)00499-8

doi: 10.1016/j.jpainsymman.2003.12.007

Journal of Pain and Symptom Management
Volume 27, Issue 2 , Pages 99-101 , February 2004

Article Tools